Atopic dermatitis and inflammatory skin diseaseSubstance P activates Mas-related G protein–coupled receptors to induce itch
Section snippets
Peptides and chemicals
SP was obtained from GenScript (Piscataway, NJ) and dissolved in 1× PBS. The NK-1R antagonist L733060 and the dual NK-1R/Mrgprs antagonist QWF (Boc-Gln-D-Trp[formyl]-Phe benzyl ester trifluoroacetate) were obtained from Sigma (St Louis, Mo). QWF and L733060 were dissolved in dimethyl sulfoxide (DMSO; Sigma) at 10 mmol/L and diluted in PBS for use at concentrations of 500 μmol/L or less. In the nociceptive studies with capsaicin, in which QWF was diluted in DMSO, the final concentration of DMSO
SP-induced itch behavior is dependent on Mrgprs
We first investigated whether Mrgprs played a role in SP-induced scratching behavior. We used the mouse cheek model17 to evaluate the pruritogenic effect of SP in Mrgpr cluster Δ−/− mice in which 12 Mrgprs had been knocked out.10 SP-induced itch was significantly decreased in these animals compared with that seen in wild-type mice (Fig 1, A). This result is consistent with previous studies suggesting a role for DRG neurons in addition to mast cells in patients with SP-induced itch.6, 14 To
Discussion
The limited efficacy of antihistamines in most pruritic conditions20, 21 highlights the importance of histamine-independent mechanisms of itch. Mrgprs are among the most important mediators of histamine-independent itch.22 This article further addresses the role of Mrgprs in itch by indicating a specific role for MrgprA1 in SP-induced itch in mice. SP has been implicated in various cutaneous and systemic pruritic disorders, such as atopic dermatitis23, 24 and cholestasis.25 We have previously
References (29)
- et al.
Aprepitant for management of severe pruritus related to biological cancer treatments: a pilot study
Lancet Oncol
(2012) - et al.
Sensory neuron-specific GPCR Mrgprs are itch receptors mediating chloroquine-induced pruritus
Cell
(2009) - et al.
Immunoglobulin E-independent activation of mast cell is mediated by Mrg receptors
Biochem Biophys Res Commun
(2006) - et al.
A diverse family of GPCRs expressed in specific subsets of nociceptive sensory neurons
Cell
(2001) - et al.
Behavioral differentiation between itch and pain in mouse
Pain
(2008) - et al.
Molecular signatures of mouse TRPV1-lineage neurons revealed by RNA-Seq transcriptome analysis
J Pain
(2014) - et al.
Involvement of substance P in scratching behaviour in an atopic dermatitis model
Eur J Pharmacol
(2004) - et al.
Serum concentrations of substance P in cholestasis
Ann Hepatol
(2010) - et al.
Expression of Mas-related gene X2 on mast cells is upregulated in the skin of patients with severe chronic urticaria
J Allergy Clin Immunol
(2014) - et al.
MrgX2 is a high potency cortistatin receptor expressed in dorsal root ganglion
J Biol Chem
(2003)
Cloning and expression of MRG receptors in macaque, mouse, and human
Brain Res Mol Brain Res
Aprepitant as an antipruritic agent?
N Engl J Med
Targeting the neurokinin receptor 1 with aprepitant: a novel antipruritic strategy
PLoS One
Topical aprepitant in clinical and experimental pruritus
Arch Dermatol
Cited by (122)
The MRGPR family of receptors in immunity
2024, ImmunityAtopic Dermatitis Itch: Scratching for an Explanation
2024, Journal of Investigative DermatologySimilarities and differences in peripheral itch and pain pathways in atopic dermatitis
2024, Journal of Allergy and Clinical ImmunologyPruritus in Dermatology: Part 1 — General Concepts and Pruritogens
2023, Actas Dermo-SifiliograficasHow to get rid of itching
2023, Pharmacology and Therapeutics
E.A. is the recipient of a grant from the National Eczema Association. S.T. holds postdoctoral fellowships from the Canadian Institute of Health and Research. Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases R01AR057744 and R21AR067399 (to E.A.L.) and the National Institute of Child Health (HD018655) and Human Development and National Institute of Neurological Disorders and Stroke (R37NS039518; to C.J.W.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest.
- ∗
These authors contributed equally to this work.